How the HAART Drug Cocktail Works

The first effective anti-retroviral treatment for HIV, Azidothymidine (AZT), was approved for treatment in 1987. But HIV is highly prone to mutations and thus likely to develop drug resistance. It wasn't until researcher David Ho thought to combine three different anti-retrovirals, in what is called a Highly Active Antiretroviral Treatment (HAART) cocktail, that AIDS became a truly controllable disease. Below, Ho talks about the "eureka moment" that led his team of researchers to develop HAART.

The HIV virus contains strands of RNA genetic material packaged along with a protein called Reverse Transcriptase. When HIV infects a T-cell (the white blood cells that normally protect the body against cellular invaders), it unloads its RNA into the T-cell. There the Reverse Transcriptase reads and transcribes the single-stranded RNA nucleotide bases into double-stranded viral DNA. Then another protein called Integrase fuses that viral DNA into the cell's genome. That infected DNA is later transcribed back into viral RNA, which is translated into virus proteins. The protein Protease cuts up and packages these proteins into new viruses that rupture from the cell and spread the infection.

There are three major classes of drugs that combat HIV at various stages of infection. Today, an effective HIV cocktail therapy will include three or four different types of the following drugs, but the exact regimen varies from person to person.

1. Nucleoside Analog Reverse Transcript Inhibitors (NRTIs) - These drugs, including AZT, disrupt reverse transcription, thereby preventing viral DNA from being created. NRTI's have a similar chemical structure as deoxynucleotides, the building blocks of DNA, and they compete with these naturally-occurring deoxynucleotides to be incorporated into the growing DNA chain during reverse transcription. But when an NRTI is incorporated into viral DNA, it terminates the production of that DNA strand, halting viral DNA synthesis.

2. Non-Nucleoside Reverse Transcript Inhibitors (NNRTIs) - These drugs, like NRTIs, halt viral DNA synthesis, but they do so through a different mechanism. NNRTIs target the Reverse Transcriptase enzyme itself, preventing it from transcribing DNA and thereby barring the virus from infecting the cell's genome.

3. Protease Inhibitors (PIs) - Pioneered for use in HIV patients by Ho, these drugs act on cells that have already been infected by viral DNA. PIs inhibit the protein Protease, which is required to produce and package new viruses that emerge from an infected cell and can attack other T-cells.

Big Think
Sponsored by Lumina Foundation

Upvote/downvote each of the videos below!

As you vote, keep in mind that we are looking for a winner with the most engaging social venture pitch - an idea you would want to invest in.

Keep reading Show less

7 fascinating UNESCO World Heritage Sites

Here are 7 often-overlooked World Heritage Sites, each with its own history.

Photo by Raunaq Patel on Unsplash
Culture & Religion
  • UNESCO World Heritage Sites are locations of high value to humanity, either for their cultural, historical, or natural significance.
  • Some are even designated as World Heritage Sites because humans don't go there at all, while others have felt the effects of too much human influence.
  • These 7 UNESCO World Heritage Sites each represent an overlooked or at-risk facet of humanity's collective cultural heritage.
Keep reading Show less

Scientists create a "lifelike" material that has metabolism and can self-reproduce

An innovation may lead to lifelike evolving machines.

Shogo Hamada/Cornell University
Surprising Science
  • Scientists at Cornell University devise a material with 3 key traits of life.
  • The goal for the researchers is not to create life but lifelike machines.
  • The researchers were able to program metabolism into the material's DNA.
Keep reading Show less

Scientists discover how to trap mysterious dark matter

A new method promises to capture an elusive dark world particle.

Surprising Science
  • Scientists working on the Large Hadron Collider (LHC) devised a method for trapping dark matter particles.
  • Dark matter is estimated to take up 26.8% of all matter in the Universe.
  • The researchers will be able to try their approach in 2021, when the LHC goes back online.
Keep reading Show less